Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004260.4(RECQL4):āc.212A>Gā(p.Glu71Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0127 in 1,569,994 control chromosomes in the GnomAD database, including 437 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E71A) has been classified as Uncertain significance.
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]
Computational evidence support a benign effect (MetaRNN=0.002013743).
BP6
Variant 8-144517415-T-C is Benign according to our data. Variant chr8-144517415-T-C is described in ClinVar as [Benign]. Clinvar id is 135158.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-144517415-T-C is described in Lovd as [Benign]. Variant chr8-144517415-T-C is described in Lovd as [Likely_benign]. Variant chr8-144517415-T-C is described in Lovd as [Likely_pathogenic].
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0572 is higher than 0.05.
Genome Diagnostics Laboratory, Amsterdam University Medical Center
-
- -
not provided, no classification provided
reference population
ITMI
Sep 19, 2013
- -
Benign, criteria provided, single submitter
clinical testing
PreventionGenetics, part of Exact Sciences
-
- -
not provided Benign:3
Likely benign, no assertion criteria provided
clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
-
- -
Benign, criteria provided, single submitter
clinical testing
GeneDx
Nov 29, 2018
This variant is associated with the following publications: (PMID: 30651579, 12734318) -
Benign, criteria provided, single submitter
not provided
Breakthrough Genomics, Breakthrough Genomics
-
- -
Baller-Gerold syndrome;C1849453:Rapadilino syndrome;C5203410:Rothmund-Thomson syndrome type 2 Benign:1
Benign, criteria provided, single submitter
clinical testing
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Jul 12, 2022
This variant has been reported in the literature in at least 2 individuals: 1 with Rothmund-Thomson syndrome and 1 with sagittal craniosynostosis (Wang 2003 PMID:12734318, Sewda 2019 PMID:30651579). However, this variant is present in the Genome Aggregation Database (Highest reported MAF 4.7% (719/15286) including 41 homozygotes (https://gnomad.broadinstitute.org/variant/8-144517415-T-C?dataset=gnomad_r3). This variant is present in ClinVar, with several labs classifying this variant as Benign (Variation ID:135158). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, this variant is not expected to cause disease and is classified as benign. -